Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of securities of Vital Farms, Inc. for the period between May 8, 2025, and February 26, 2026, due to alleged misleading statements regarding the company's new enterprise resource planning (ERP) system and its impact on earnings [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Vital Farms downplayed the risks associated with the rollout of its ERP system, which ultimately led to delays affecting the company's earnings guidance for 2025 [5]. - It is alleged that the company made false statements about its business operations and prospects, which were materially misleading [5]. - Investors are encouraged to join the class action to seek compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by May 26, 2026, to represent other class members in the litigation [1][3]. - No class has been certified yet, and investors can choose to remain absent or select their own counsel [7]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been recognized for its success in securities class action settlements, ranking in the top 4 since 2013 and recovering hundreds of millions for investors [4].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of securities of Vital Farms, Inc. for the period between May 8, 2025, and February 26, 2026, due to alleged misleading statements regarding the company's new enterprise resource planning (ERP) system and its impact on financial performance [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Vital Farms downplayed the risks associated with the rollout of its ERP system, which led to delays that caused the company to miss its full year 2025 earnings guidance and earnings per share consensus [5]. - Defendants allegedly made materially false and misleading statements about Vital Farms' business operations and prospects throughout the class period [5]. Group 2: Investor Information - Investors who purchased Vital Farms securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - Tennant Company experienced a significant decline in stock price due to issues with its new ERP system, leading to an investigation into potential violations of federal securities laws [1][6]. Group 1: Financial Performance - Tennant's GAAP net income for 2025 was reported at $43.8 million, representing a year-over-year decrease of approximately 47% [4]. - In Q4 2025, the company reported a net loss that was 166% lower than the net income from the same period the previous year [4]. - The financial impact of the ERP issues was quantified by management, estimating a $30 million loss in net sales due to operational disruptions [5]. Group 2: ERP System Issues - The North America ERP system went live in early November 2025, introducing severe functionality issues that hindered order entry, product shipping, and customer service [5]. - Management indicated that the challenges faced in Q4 2025 would extend into early 2026, affecting overall operations [5]. Group 3: Market Reaction and Investigation - Following the announcement of the ERP issues, Tennant's market capitalization decreased by approximately $343 million [6]. - Hagens Berman is investigating the timeline of when Tennant became aware of the ERP problems and whether any critical information was concealed from investors [6].

Core Insights - The Clorox Company (CLX) reported first-quarter fiscal 2026 results with both revenue and earnings exceeding Zacks Consensus Estimates but showing a year-over-year decline [1][12] - The company achieved a significant milestone by launching a new enterprise resource planning (ERP) system in the U.S., enhancing its digital capabilities and operational adaptability [2][12] Financial Performance - Adjusted earnings were reported at 85 cents per share, surpassing the Zacks Consensus Estimate of 78 cents, but reflecting a 54% decrease from $1.86 per share in the same quarter last year [4][12] - Net sales totaled $1.43 billion, down 19% year-over-year, primarily due to lower shipments related to the ERP transition, although it exceeded the consensus estimate of $1.38 billion [5][12] - Gross profit fell 26.1% year-over-year to $596 million, with gross margin contracting by 410 basis points to 41.7% due to reduced volumes and increased manufacturing and logistics costs [6][12] Segment Performance - The Health and Wellness segment saw a 19% decline in sales to $565 million, with a 16-point decrease in volume and a three-point unfavorable price mix [7] - The Household segment reported a 19% decrease in net sales to $362 million, attributed to a one-point unfavorable price mix and lower volumes [8] - The Lifestyle segment experienced a 23% drop in sales to $245 million, reflecting a one-point negative price mix and lower volumes [9] - The International segment's net sales decreased by 2% to $253 million, impacted by lower volumes and shipments related to the ERP transition [10] Financial Position - Clorox ended the quarter with cash and cash equivalents of $166 million, long-term debt of $2.49 billion, and stockholders' deficit equity of $22 million, excluding non-controlling interest [11] Guidance for FY26 - Management maintains its fiscal 2026 outlook for net sales, gross margin, and adjusted EPS, projecting a net sales decline of 6-10% compared to the prior year [13][14] - Organic sales are expected to decrease by 5-9%, largely due to a 7.5 percentage point decline from the reversal of incremental shipments made in the previous year [14] - The gross margin is projected to decline by 50-100 basis points, with a significant portion attributed to the ERP-related shipment impact from the prior year [15] - Earnings per share (EPS) guidance is set between $5.60 and $5.95, indicating a year-over-year decrease of 9-14% [17] - Adjusted EPS is anticipated to be between $5.95 and $6.30, reflecting a decline of 18-23% from the previous year [18]